Video

Dr. Cusnir on the Most Effective Uses of Chemotherapy Treatment in CRC

Author(s):

Mike Cusnir, MD, discusses the most effective uses of chemotherapy in colorectal cancer.

Mike Cusnir, MD, chief, Division of Hematology and Oncology, co-director, Gastrointestinal Malignancies, Mount Sinai Medical Center, discusses the most effective uses of chemotherapy in colorectal cancer (CRC).

Chemotherapy is typically effective in all lines of CRC, Cusnir says. Chemotherapy has been used in a variety of settings, from adjuvant therapy to curative intent, Cusnir adds. A role for chemotherapy can also be found in the advanced setting for patients with stage IV disease, Cusnir explains.

One key factor when evaluating a patient for the use of chemotherapy is the risk of adverse effects, Cusnir continues. Clinicians must consider how to limit chemotherapy-related toxicities for patients without compromising survival and quality of life, Cusnir concluded.

Related Videos
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.